Skip to content

Doctor's duty in incorporating expectant and nursing mothers into medical trials

Untested drugs and treatments remain unavailable for them, due to insufficient data on safety.

Untested treatments are scarcely accessible for them, attributed to insufficient safety data.
Untested treatments are scarcely accessible for them, attributed to insufficient safety data.

Doctor's duty in incorporating expectant and nursing mothers into medical trials

Pregnant and breastfeeding women are often overlooked in clinical trials worldwide, prompting a call for change from researchers to address this critical knowledge gap. Dr. Natalie Dayan, an obstetrician-internist at McGill University Health Centre's Research Institute, initiated the PregTrial initiative to establish safer guidelines for including these women in such trials.

Women who are pregnant or breastfeeding are often denied access to the latest treatments for chronic diseases due to a lack of relevant data regarding their safety. Moreover, doctors frequently prescribe medications that haven't been thoroughly tested in these populations, potentially exposing them to either less effective drugs or treatments with poorly understood risks.

To rectify this situation, Dr. Dayan has been working to introduce a maternal investigation framework that prioritizes the inclusion of pregnant and breastfeeding women in relevant clinical research. She emphasizes that this isn't about including them in every trial, but rather focusing on studies concerning chronic or infectious diseases that can cause severe complications, as well as infectious diseases like COVID-19 that affect broad populations.

The first step in implementing this framework is to conduct tests on pregnant animals to evaluate whether a drug can cross the placenta and reach the fetus. Following this, small pre-clinical trials can be carried out with informed volunteers, who will be closely monitored throughout the process. Once the appropriate dose is established and the drug's safety is demonstrated in the general population, more pregnant or breastfeeding women can be included in subsequent trials.

Inclusion of pregnant and breastfeeding women in clinical trials is essential for generating accurate data on medication safety and efficacy during pregnancy and breastfeeding. This information is crucial for developing better-informed treatment guidelines that prioritize the health and well-being of both mothers and infants.

The 'exclusion culture' of pregnant and breastfeeding women in medication research, to some extent, stems from the thalidomide disaster of the 1950s and 1960s, during which the drug caused severe birth defects in infants when given to pregnant women. While clinical trial standards have been strengthened since then to prevent such events, the fear remains. Balancing potential risks with the benefits of acquiring robust data is important when considering these studies.

By developing and implementing a structured, ethical, and scientifically rigorous framework for including pregnant and breastfeeding women in clinical trials, we can fill critical knowledge gaps and establish a new standard for maternal and infant health research. This approach will ultimately lead to better-informed treatment guidelines during pregnancy and breastfeeding, benefiting both mothers and infants worldwide.

  1. The French government is investing in environmental science to aid in understanding climate change impacts on global health-and-wellness, particularly regarding chronic diseases like type-2 diabetes, cancer, and respiratory conditions.
  2. Many women suffer from digestive-health issues during pregnancy and breastfeeding, prompting a need for comprehensive studies in these areas.
  3. The manufacturing industry is exploring new therapies-and-treatments for autoimmune-disorders, aiming to improve women's-health, including addressing concerns related to menopause and cardiovascular-health.
  4. In the retail sector, companies are promoting skin-care products that are safe for women during pregnancy and breastfeeding, responding to increased consumer awareness.
  5. Mental-health institutions are implementing programs specifically designed for pregnant and breastfeeding women, recognizing the importance of emotional well-being during this critical phase.
  6. The hearing health industry is developing effective treatments for common ear infections that affect pregnant women, ensuring the well-being of both mothers and infants.
  7. Using advancements in medical-conditions research, innovators are developing smartphones with built-in health monitoring features, including heart rate, blood pressure, and blood sugar level readings, benefiting women during pregnancy and breastfeeding.
  8. The finance sector encourages investing in women's-healthcare startups, recognizing the potential for improved maternal-and-infant health and reducing the burden of chronic diseases.
  9. Wealth-management firms offer personal-finance advice tailored to pregnant and breastfeeding women, helping them manage expenses related to health-care costs and other living expenses.
  10. In the aviation industry, there's a growing focus on providing safe, comfortable, and accessible transportation for pregnant women during travel.
  11. Public-transit systems are evaluating their services to ensure they cater to the needs of pregnant and breastfeeding women, ensuring safe and convenient travel options.
  12. The residential sector is implementing flexibility in lease agreements and housing-market options for new and expectant mothers, promoting a sense of security and ease during this critical phase.
  13. The venture-capital community is investing in startups that focus on developing safe and effective contraceptives to address unmet needs in women's-health.
  14. Small-business owners prioritize diversity-and-inclusion in their workplace-wellness initiatives, ensuring that their female employees have access to resources and support during pregnancy and breastfeeding.
  15. The automotive industry is developing connected wearables for drivers, incorporating features like heart rate and blood pressure monitoring to ensure road safety during pregnancy.
  16. Environmental scientists are studying the effects of climate-change on eye-health, particularly for pregnant and breastfeeding mothers exposed to increased pollution levels.
  17. Entrepreneurship programs are empowering women to start their own businesses, offering them flexibility in managing work and family responsibilities during pregnancy and breastfeeding.
  18. The banking-and-insurance sector is offering insurance policies specific to women's-health concerns during pregnancy and breastfeeding, addressing gaps in coverage and alleviating financial stress.
  19. Fintech companies are developing innovative solutions for debt-management and budgeting, designed to help families manage financial growth and stability during this critical phase.
  20. Real-estate developers are incorporating green spaces and reduced pollution levels in residential projects to improve the overall health-and-wellness of pregnant and breastfeeding mothers living nearby.
  21. The commercial sector understands the importance of supporting breastfeeding mothers in the workplace, offering lactation rooms and resources to make the transition back to work easier.
  22. The energy industry, through investments in renewable sources, aims to minimize air pollution that may be harmful to pregnant and breastfeeding mothers.
  23. Technology companies are designing gadgets that cater to pregnant women's needs, such as wearable devices for tracking fetal development and motion sensors for fall detection.
  24. Healthcare providers recognize the significance of addressing hearing issues in pregnant women, providing solutions that can help identify potential complications during pregnancy.
  25. Skin-care brands are formulating products that are safe for pregnant and breastfeeding women, addressing the needs for gentle and effective skincare during this critical phase.
  26. The stock-market is influenced by the performance of pharmaceutical and healthcare companies that prioritize researching treatment options for pregnant and breastfeeding women, specifically regarding medications for common skin-conditions.
  27. Private-equity firms are investing in companies that focus ondeveloping innovative therapies-and-treatments for women's-health, addressing gaps in knowledge about conditions like autoimmune-disorders and mental-health concerns.
  28. To support the financial goals of pregnant and breastfeeding mothers, wealth-management firms provide guidance on saving, planning, and minimizing debt to ensure a stable future for families.

Read also:

    Latest